AUPH - Aurinia Pharmaceuticals Inc.'s (AUPH) CEO Peter Greenleaf on Q3 2019 Results - Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Q3 2019 Earnings Conference Call
November 14, 2019 4:30 PM ET
Company Participants
Glenn Schulman - Investor Relations
Peter Greenleaf - Chief Executive Officer
Dennis Bourgeault - Chief Financial Officer
Neil Solomons - Chief Medical Officer
Michael Martin - Chief Operating Officer
Conference Call Participants
Alethia Young - Cantor Fitzgerald
Joseph Schwartz - SVP Leerink
Ed Arce - H.C. Wainwright
Justin Kim - Oppenheimer & Company
Presentation
Operator
Greetings, and welcome to the Aurinia Pharmaceuticals Third Quarter 2019 Conference Call. At this time, all participants are in a listen-only mode. A